Table 1 Demographics and characteristics at core study baseline of patients who switched treatments
Demographic variable | Crossed over to pasireotide LAR (N = 81) | Crossed over to octreotide LAR (N = 38) |
|---|---|---|
Median age (range), years | 45.0 (24–85) | 48.5 (25–64) |
Female, n (%) | 38 (46.9) | 22 (57.9) |
Race, n (%) | ||
Caucasian | 42 (51.9) | 20 (52.6) |
Black | 1 (1.2) | 1 (2.6) |
Asian | 26 (32.1) | 8 (21.1) |
Native American | 3 (3.7) | 1 (2.6) |
Other | 9 (11.1) | 8 (21.1) |
Median time since diagnosis prior to enrollment in the core study, months | 7.1 | 4.2 |
Previous surgery, n (%) | 35 (43.2) | 10 (26.3) |
Previous irradiation, n (%) | 0 (0) | 0 (0) |
Median time since surgery prior to enrollment in the core study, months | 6.6 | 10.3 |